KR850004983A - 고순도 히알우론산의 제조방법 - Google Patents

고순도 히알우론산의 제조방법 Download PDF

Info

Publication number
KR850004983A
KR850004983A KR1019840007377A KR840007377A KR850004983A KR 850004983 A KR850004983 A KR 850004983A KR 1019840007377 A KR1019840007377 A KR 1019840007377A KR 840007377 A KR840007377 A KR 840007377A KR 850004983 A KR850004983 A KR 850004983A
Authority
KR
South Korea
Prior art keywords
hyaluronic acid
strain
group
protein
high purity
Prior art date
Application number
KR1019840007377A
Other languages
English (en)
Other versions
KR880001763B1 (ko
Inventor
케이.브라운 카렌
Original Assignee
유진 시모 네일
밀즈 래보레이토리스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 유진 시모 네일, 밀즈 래보레이토리스, 인코포레이티드 filed Critical 유진 시모 네일
Publication of KR850004983A publication Critical patent/KR850004983A/ko
Application granted granted Critical
Publication of KR880001763B1 publication Critical patent/KR880001763B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

고순도 히알우론산의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1 내지 3도는 본 발명에 의한 네가지 미생물학적 발효에 의해 제조된 HA의 분자량 분포를 나타내는 그래프이다.

Claims (4)

  1. 히알우로니다제-음성 또는 히알우로니 다제가 역제된 히알우론산 생성 균주를, 이 균주내에 보다 많은 양의 히알우론산을 생성시키기에 충분한 조건하에 단백질을 거의 함유하지 않는 배지중에서 배양하고, 배양액으로부터 히알우론산을 추출하고, 단백질 결합 여과에 의해 반응성 단백질을 제거하는 단계로 구성됨을 특징으로 하여 히알우론산을 제조하는 방법.
  2. 제1항에 있어서, 균주가 그룹 A 및 그룹 C 용혈성 연쇄상 구균으로 구성되는 그룹으로부터 선정되는 방법.
  3. 제1항에 있어서, 균주가 스트렙토코쿠스에퀴(Streptococcus cqui.)인 방법.
  4. 제1항에 있어서, 추출단계 다음에, 단백질 함량이 약 1.25mg/ml미만, 핸산 농도가 약 45㎍/ml 미만으로 될 때까지 알코올 침전 및 H2O 용해를 반복하고, 니트로 셀룰로오스를 통해 여과시키는 단계로 이루어진 정제 공정이 수행되는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840007377A 1983-11-25 1984-11-24 고순도 히알우론산의 제조방법 KR880001763B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55522483A 1983-11-25 1983-11-25
US555,224 1983-11-25
US555224 1983-11-25

Publications (2)

Publication Number Publication Date
KR850004983A true KR850004983A (ko) 1985-08-19
KR880001763B1 KR880001763B1 (ko) 1988-09-12

Family

ID=24216466

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840007377A KR880001763B1 (ko) 1983-11-25 1984-11-24 고순도 히알우론산의 제조방법

Country Status (18)

Country Link
US (1) US4782046A (ko)
EP (1) EP0144019B1 (ko)
JP (1) JPS60133894A (ko)
KR (1) KR880001763B1 (ko)
AT (1) ATE53607T1 (ko)
AU (1) AU573768B2 (ko)
CA (1) CA1270219A (ko)
CS (1) CS249531B2 (ko)
DE (1) DE3482479D1 (ko)
DK (1) DK558884A (ko)
ES (1) ES537938A0 (ko)
FI (1) FI79555C (ko)
HU (1) HU192617B (ko)
IE (1) IE57688B1 (ko)
IL (1) IL73605A (ko)
NO (1) NO161573C (ko)
NZ (1) NZ210300A (ko)
ZA (1) ZA849025B (ko)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
US4780414A (en) * 1985-01-18 1988-10-25 Bio-Technology General Corp. Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
EP0221167A4 (en) * 1985-05-09 1988-08-24 David Cullis-Hill PRODUCTION OF HYALURONIC ACID.
JPS6279790A (ja) * 1985-09-30 1987-04-13 Toyo Jozo Co Ltd 改質されたヒアルロン酸の製造法
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5023175A (en) * 1986-05-01 1991-06-11 Kabushiki Kaisha Yakult Honsha Novel production process of hyaluronic acid and bacterium strain therefor
JPH072117B2 (ja) * 1986-10-09 1995-01-18 三菱レイヨン株式会社 ヒアルロン酸の製造法
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
FR2617849B1 (fr) * 1987-07-10 1992-05-15 Pf Medicament Nouveau procede d'obtention d'acide hyaluronique d'origine bacterienne
JPH0813847B2 (ja) * 1987-08-11 1996-02-14 日本化薬株式会社 ヒアルロン酸の分画法
JPS6467196A (en) * 1987-09-08 1989-03-13 Yakult Honsha Kk Production of hyaluronic acid and strain used therefor
JP2938880B2 (ja) * 1988-10-12 1999-08-25 電気化学工業株式会社 ヒアルロン酸の精製法
HU203372B (en) 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
US5015577A (en) * 1989-08-29 1991-05-14 Board Of Regents, The University Of Texas System DNA encoding hyaluronate synthase
WO1991011992A1 (en) * 1990-02-13 1991-08-22 Zerega Gere S Di Peritoneal induced medicaments
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
GB9024223D0 (en) * 1990-11-07 1990-12-19 Fermentech Ltd Production of hyaluronic acid
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
IT1247175B (it) * 1991-04-19 1994-12-12 Fidia Spa Procedimento per la purificazione di acido ialuronico e frazione di acido ialuronico puro per uso oftalmico.
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
AU3065192A (en) * 1991-12-20 1993-07-28 Howmedica Inc. Ultra-pure polysaccharide materials for medical use
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
IT1268954B1 (it) * 1994-03-11 1997-03-18 Fidia Advanced Biopolymers Srl Processo per la preparazione di acido ialuronico mediante sintesienzimatica e relative composizioni farmaceutiche
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
SE9401806D0 (sv) * 1994-05-26 1994-05-26 Pharmacia Ab Method and means for the production of hyaluronic acid
US6455304B1 (en) 1994-07-01 2002-09-24 The Board Of Regents Of The University Of Oklahoma Hyaluronate synthase gene and uses thereof
US6951743B2 (en) 1997-10-31 2005-10-04 University Of Oklahoma Board Of Regents Hyaluronan synthase genes and expression thereof in bacillus hosts
US7091008B1 (en) 1994-07-01 2006-08-15 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthase genes and expression thereof in Bacillus hosts
KR19980080116A (ko) * 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
DE69828193T2 (de) 1997-10-31 2005-12-01 The Board Of Regents Of The University Of Oklahoma, Norman Hyaluronan synthase gen und seine verwendung
CN101113436B (zh) * 1997-10-31 2013-02-06 俄克拉何马大学董事会 透明质酸合酶基因及其应用
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US6987023B2 (en) 1998-04-02 2006-01-17 The Board Of Regents Of The University Of Oklahoma DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US7223571B2 (en) 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US7094581B2 (en) 1998-10-26 2006-08-22 The Board Of Regents Of The University Of Oklahoma Hyaluronan synthases and methods of making and using same
AU2745700A (en) 1999-02-01 2000-08-18 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US20050287638A1 (en) * 2000-04-25 2005-12-29 Weigel Paul H Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
US7879824B2 (en) * 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US20070020737A1 (en) * 2001-12-03 2007-01-25 Pummill Philip E Hyaluronan synthases and methods of making and using same
DE60311463T2 (de) 2002-06-20 2007-11-15 Novozymes Biopolymer A/S Ausflockung mit zweiwertigem salz
US20040126853A1 (en) * 2002-06-20 2004-07-01 Novozymes A/S Flocculation with divalent salt
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7485629B2 (en) * 2002-10-16 2009-02-03 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treatment of joint damage
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
US20080003258A1 (en) * 2002-10-16 2008-01-03 Marcum Frank D Composition and Method for Treating Rheumatoid Arthritis
US7002007B2 (en) * 2004-05-28 2006-02-21 Calcigen Corporation Production of high molecular weight hyaluronates
KR100577075B1 (ko) * 2004-06-16 2006-05-08 주식회사 티앤라이프시스템 칼슘염 및 인산염, 또는 인산칼슘염을 이용한 히아루론산정제방법
CA2624338C (en) 2005-10-05 2016-09-13 Bayer Cropscience Ag Plants having an increased content of amino sugars
EP1772052A1 (de) 2005-10-05 2007-04-11 Bayer CropScience GmbH Verbesserte Verfahren und Mittel zur Herstellung von Hyaluronan
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
US8852948B2 (en) * 2007-08-29 2014-10-07 Cem Corporation Colorimetric protein analysis method
US8147759B2 (en) * 2007-08-29 2012-04-03 Cem Corporation Automated protein analyzer
EP2036983A1 (de) 2007-09-12 2009-03-18 Bayer CropScience AG Pflanzen, die erhöhte Mengen an Glucosaminglycanen synthetisieren
WO2009063291A1 (en) * 2007-11-13 2009-05-22 Bio-Technology General (Israel) Ltd. Dilute filtration sterilization process for viscoelastic biopolymers
KR101322227B1 (ko) 2011-09-30 2013-10-28 일동제약주식회사 스트렙토코커스 디스갈락티애 ｉｄ9103 균주 및 이를 이용한 히알루론산 생산 방법
EP2886104A1 (en) 2013-12-11 2015-06-24 Patir, Suleyman An intra-articular gel
CA2896038C (en) 2015-07-03 2022-08-09 Glycobiosciences Inc. Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof
WO2017106782A1 (en) * 2015-12-18 2017-06-22 Tega Therapeutics, Inc. Cellular glycosaminoglycan compositions and methods of making and using
DE102015226456A1 (de) * 2015-12-22 2017-06-22 Heraeus Medical Gmbh Verfahren zur Sterilisation von wässrigen Polysaccharidlösungen und sterile wässrige Polysaccharidlösungen
DE102016208567A1 (de) * 2016-05-19 2017-11-23 Heraeus Medical Gmbh Polymerlösung zur Viscosupplementation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2599172A (en) * 1948-11-29 1952-06-03 Searle & Co Sulfuric acid esters of hyaluronic acid and processes for the production thereof
US2975104A (en) * 1959-05-21 1961-03-14 American Home Prod Medium and method for producing and isolating hyaluronic acid
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
FR2298599A2 (fr) * 1975-01-24 1976-08-20 Sifrance Nouvelles compositions detergentes solides non corrosives
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
US4328803B1 (en) 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
JPS5837001A (ja) * 1981-08-27 1983-03-04 Green Cross Corp:The ヒアルロン酸の製造法
JPS5857319A (ja) * 1981-09-30 1983-04-05 Green Cross Corp:The 高粘性ヒアルロン酸製剤
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.

Also Published As

Publication number Publication date
KR880001763B1 (ko) 1988-09-12
HU192617B (en) 1987-06-29
EP0144019B1 (en) 1990-06-13
AU3580684A (en) 1985-05-30
IL73605A (en) 1992-03-29
DK558884D0 (da) 1984-11-23
FI79555B (fi) 1989-09-29
US4782046A (en) 1988-11-01
DE3482479D1 (de) 1990-07-19
CS249531B2 (en) 1987-03-12
AU573768B2 (en) 1988-06-23
ATE53607T1 (de) 1990-06-15
HUT36180A (en) 1985-08-28
JPS60133894A (ja) 1985-07-17
CA1270219A (en) 1990-06-12
IE843003L (en) 1985-05-25
ES8603578A1 (es) 1985-12-16
DK558884A (da) 1985-05-26
ZA849025B (en) 1985-07-31
ES537938A0 (es) 1985-12-16
NO161573B (no) 1989-05-22
EP0144019A2 (en) 1985-06-12
IL73605A0 (en) 1985-02-28
NO161573C (no) 1989-08-30
FI844597L (fi) 1985-05-26
NO844493L (no) 1985-05-28
IE57688B1 (en) 1993-02-24
FI79555C (fi) 1990-01-10
FI844597A0 (fi) 1984-11-22
EP0144019A3 (en) 1986-10-08
NZ210300A (en) 1989-06-28

Similar Documents

Publication Publication Date Title
KR850004983A (ko) 고순도 히알우론산의 제조방법
KR850007983A (ko) 히알우론산 생산의 발효법
FI844091L (fi) Framstaellning av hyaluronsyra medelst bakteriekultur.
US4596709A (en) Novel immunostimulating glycoproteins
CA2084714A1 (en) Bioleaching Method for the Extraction of Metals from Coal Fly Ash Using Thiobacillus
US4591563A (en) Process for the purification of dextran-sucrase
KR840003696A (ko) 2-케토-l-굴론산의 제조방법
Yamakawa et al. Preferential transcription of Bacillus subtilis light deoxyribonucleic acid strands during sporulation
Michaud et al. Physicochemical properties of extracellular (1→ 4)-β-D-glucuronan produced by the Rhizobium meliloti M5N1CS strain during fermentation: Evidence of degradation by an exoenzyme activated by Mg2+
US5326705A (en) Process for producing optically active 1,3-butandiol by asymmetric assimilation
US5348875A (en) Production of alginase from Enterobacter cloacae M-1 (FERM BP-2577)
KR910006489A (ko) 세포외의 엑소폴리머 이것의 제조방법 및 그러한 엑소폴리머를 함유하는 제약학적 조성물
ATE200913T1 (de) Herstellung von l - ascorbinsäure in mikroorganismen
DE68911367T2 (de) Verfahren zur Herstellung eines Mikroorganismus, Verwendung dieses Mikroorganismus zur Herstellung eines Heteropolysaccharids sowie dafür brauchbare Mikroorganismen.
JPS57188600A (en) Novel actinomycetic plasmid
KR840005742A (ko) 항균성 및 항종양성 항생물질 m9026과 그의 순수한 각 분획물 1,2 및 3의 제조방법
KR910016916A (ko) 미생물 및 이를 이용한 바이오틴 바이타머의 생산방법
KR850001537A (ko) 림포톡신 및 림포톡신- mRNA의 제조방법
JPS5982088A (ja) ピキア属菌によるソルビト−ルの製造法
Michaud et al. Cyclic (1→ 2)-β-d-glucans excreted by the glucuronan-producing strain Rhizobium meffloti M5N1CS CS (NCIM B 40472) and by the succinoglycan-producing strain Rhizobium meliloti M5N1
KR900003747B1 (ko) 세라티오펩티다제(Serratio peptidase)의 정제방법
KR860007382A (ko) 히아론산의 정제방법
GB1208225A (en) Process for purifying l-asparaginase
JP3148342B2 (ja) レバン型フルクタンの製造に適した新規細菌
FUKUI et al. CHEMICAL AND BIOCHEMICAL STUDIES ON VITAMIN B12 AND ITS RELATED COMPOUNDS XII. PRODUCTION OF 5, 6-DIMETHYLBENZIMIDAZOLYLCOBAMIDE COENZYME BY CELL SUSPENSION OF PROPIONIBACTERIUM SHERMANII

Legal Events

Date Code Title Description
N231 Notification of change of applicant
A201 Request for examination
G160 Decision to publish patent application
O035 Opposition [patent]: request for opposition

Free format text: OPPOSITION NUMBER: 001988001061001988001513; OPPOSITION DATE: 23770801

O122 Withdrawal of opposition [patent]
E701 Decision to grant or registration of patent right
O073 Decision to grant registration after opposition [patent]: decision to grant registration
GRNT Written decision to grant
J204 Request for invalidation trial [patent]
J202 Request for trial for correction [limitation]
J2X1 Appeal (before the patent court)

Free format text: CORRECTION

Free format text: TRIAL NUMBER: 1993200000279; CORRECTION

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION IN ENTIRETY

Free format text: TRIAL NUMBER: 1995200000034; INVALIDATION IN ENTIRETY

EXTG Ip right invalidated
FPAY Annual fee payment

Payment date: 19970827

Year of fee payment: 10